Persistence of humoral response against sporozoite and blood-stage malaria antigens 7 years after a brief exposure to Plasmodium vivax.
Where this comes from
- Record sourced from PubMed, PMID 9535000.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The persistence of malarial antibodies was evaluated in subjects living in a rural community (in Minas Gerais State, Brazil) briefly exposed to a Plasmodium vivax malaria outbreak outside of the area in which malaria was endemic. Transmission was interrupted by treatment of all patients and their relatives and/or neighbors, although the latter had neither symptoms nor blood parasites. Antibodies to P. vivax antigens (recombinant proteins from sporozoites [rPvCS] and from blood stages [rPv200]) were measured in parallel by ELISA with sera collected at two time points after transmission. Anti-rPvCS IgG antibodies were positive in approximately 40% and 20% of the subjects 8 months and 7 years after exposure, respectively. Anti-rPv200 IgG was first detected in 61% of the subjects who had had malarial symptoms and remained positive in 47% after 7 years. Among the prophylactically treated group, anti-rPv200 IgG was detected in only 28% after 8 months. The levels of both antibodies decreased with time in all positive subjects.
Medical subject headings
- Antibodies, Protozoan
- Antigens, Protozoan
- Malaria, Vivax
- Plasmodium vivax